US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 15, 2014 (12 years ago)

Levofloxacin 750 mg/250 mL D5W

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

What was recalled

Levofloxacin 750 mg/250 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx #29184, Discard After 05/28/14

Recalling firm
Franck's Lab Inc dba Trinity Care Solutions
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1453-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Levofloxacin recalls

See all
Class II · Moderate risk Ongoing

Levofloxacin Ophthalmic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0820-2023
Class II · Moderate risk Ongoing

Levofloxacin Oral Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0819-2023
Class II · Moderate risk Ongoing

Levofloxacin Injection 500mg/20 mL

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0818-2023
Class III · Low risk Terminated

Levofloxacin Tablets

Reason Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

Macleods Pharma USA, INC NDC 33342-022-08 D-0162-2023